AI assistant
Sending…
DAVITA INC. — Director's Dealing 2013
May 15, 2013
30643_dirs_2013-05-15_b7855737-0e37-4888-9b91-49dc334c4248.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2013-05-13
Reporting Person: Nissenson Allen (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-13 | Common Stock | M | 1200 | $46.26 | Acquired | 2454 | Direct |
| 2013-05-13 | Common Stock | F | 424 | $131.19 | Disposed | 2030 | Direct |
| 2013-05-13 | Common Stock | S | 776 | $130.37 | Disposed | 1254 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-13 | Stock Appreciation Right | $46.26 | M | 1200 | Disposed | 2014-03-02 | Common Stock (1200) | Direct |
Footnotes
F1: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25